BioSpecifics Technologies Reveals Positive Top-Line Results From Stage 2 Study Of CCH For Treatment of Human Lipoma

By: via Benzinga
BioSpecifics Technologies Corp. (NASDAQ: BSTC) revealed Monday positive, statistically significant top-line results from its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.